Future Advances in Anti-Obesity Medications (Masters Track)
Recorded during Obesity Medicine 2022.
CME/CE Expiration Date: 6/19/25
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
Learning Objectives
- Describe current metabolic targets of anti-obesity medications
- Identify key future metabolic targets of anti-obesity medications
- Discuss the status of promising future anti-obesity medications and their role in obesity treatment
Louis Aronne, MD, FACP, DABOM
The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Obesity Medicine Association designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Obesity Medicine Association designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.